Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew C Cheung

Showing results (81-90 of 147) with videos related to

Pageof 15
Sort By:
Cancer|June 23, 2017
The impact of cancer drug wastage on economic evaluationsJudy Truong, Matthew C Cheung, Helen Mai, et al.
Blood Advances|May 2, 2024
ASH Guideline Oversight Subcommittee Response to Jacobs et al regarding Industry Payments to ASH Guideline PanelistsMenaka Pai, Michael Byrne, Adam Cuker, et al.
Blood Advances|September 22, 2023
ASH Clinical Practice Guidelines: strategies to stay up-to-dateMatthew C Cheung, Rob Kunkle, Rob Plovnick, et al.
Journal of Oncology Practice|March 31, 2018
Examining Trends in Cost and Clinical Benefit of Novel Anticancer Drugs Over TimeRonak Saluja, Vanessa S Arciero, Sierra Cheng, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 26, 2021
Reassessing the Net Benefit of Cancer Drugs With Evolution of Evidence Using the ASCO Value FrameworkSeanthel Delos Santos, Noah Witzke, Bishal Gyawali, et al.
British Journal of Haematology|October 27, 2023
Indolent lymphoma care delivery and outcomes during the COVID-19 pandemic in Ontario, CanadaInna Y Gong, Anca Prica, Zharmaine Ante, et al.
Cancer|August 28, 2009
Venous thromboembolism and nonsmall cell lung cancer: a pooled analysis of National Cancer Institute of Canada Clinical Trials Group trialsLisa K Hicks, Matthew C Cheung, Keyue Ding, et al.
Clinical Trials (London, England)|April 19, 2021
Minimization of resource utilization data collected within cost-effectiveness analyses conducted alongside Canadian Cancer Trials Group phase III trialsMatthew C Cheung, Kelvin Kw Chan, Shane Golden, et al.
Blood Advances|July 18, 2024
Health care utilization and costs for frail vs nonfrail patients with diffuse large B-cell lymphomaAbi Vijenthira, Andrew Calzavara, Chenthila Nagamuthu, et al.
JAMA Network Open|January 11, 2022
Analysis of Platelet Count and New Cancer Diagnosis Over a 10-Year PeriodVasily Giannakeas, Joanne Kotsopoulos, Matthew C Cheung, et al.
Pageof 15

Showing results (81-90 of 147) with videos related to

Sort By:
Pageof 15
Cancer|June 23, 2017
The impact of cancer drug wastage on economic evaluationsJudy Truong, Matthew C Cheung, Helen Mai, et al.
Blood Advances|May 2, 2024
ASH Guideline Oversight Subcommittee Response to Jacobs et al regarding Industry Payments to ASH Guideline PanelistsMenaka Pai, Michael Byrne, Adam Cuker, et al.
Blood Advances|September 22, 2023
ASH Clinical Practice Guidelines: strategies to stay up-to-dateMatthew C Cheung, Rob Kunkle, Rob Plovnick, et al.
Journal of Oncology Practice|March 31, 2018
Examining Trends in Cost and Clinical Benefit of Novel Anticancer Drugs Over TimeRonak Saluja, Vanessa S Arciero, Sierra Cheng, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 26, 2021
Reassessing the Net Benefit of Cancer Drugs With Evolution of Evidence Using the ASCO Value FrameworkSeanthel Delos Santos, Noah Witzke, Bishal Gyawali, et al.
British Journal of Haematology|October 27, 2023
Indolent lymphoma care delivery and outcomes during the COVID-19 pandemic in Ontario, CanadaInna Y Gong, Anca Prica, Zharmaine Ante, et al.
Cancer|August 28, 2009
Venous thromboembolism and nonsmall cell lung cancer: a pooled analysis of National Cancer Institute of Canada Clinical Trials Group trialsLisa K Hicks, Matthew C Cheung, Keyue Ding, et al.
Clinical Trials (London, England)|April 19, 2021
Minimization of resource utilization data collected within cost-effectiveness analyses conducted alongside Canadian Cancer Trials Group phase III trialsMatthew C Cheung, Kelvin Kw Chan, Shane Golden, et al.
Blood Advances|July 18, 2024
Health care utilization and costs for frail vs nonfrail patients with diffuse large B-cell lymphomaAbi Vijenthira, Andrew Calzavara, Chenthila Nagamuthu, et al.
JAMA Network Open|January 11, 2022
Analysis of Platelet Count and New Cancer Diagnosis Over a 10-Year PeriodVasily Giannakeas, Joanne Kotsopoulos, Matthew C Cheung, et al.
Pageof 15